Product ID |
Product Name |
CAS# |
Purity |
Y3162395 |
4-AMinothieno[2,3-b][1,5]benzodiazepine-2-carboxaldehyde Hydrochloride |
186792-96-1 |
95% |
Y3312462 |
Descarboxyl Levofloxacin |
178964-53-9 |
95% |
Y1341222 |
D-hydroxyphenylglycylamoxicillin) |
188112-75-6 |
93% |
Y3128111 |
Carbonyl[5,10,15,20-tetrakis(2,3,4,5,6-pentafluorophenyl)-21H,23H-porphinato]rutheniuM(II) |
171899-61-9 |
98% |
Y3304771 |
cis-Terbinafine Hydrochloride |
176168-78-8 |
95% |
Y3164155 |
5-Chlorosalicylic Acid Ethyl Ester |
15196-83-5 |
95% |
Y3287842 |
Bisacodyl Related Compound B (20 mg) (2,4'-(Pyridin-2-ylmethylene)diphenol) |
16985-05-0 |
95% |
D770677 |
9,10-Dihydro-9,10-[1,2]benzenoanthracene-9-yl bromide |
15364-55-3 |
98.0% |
Y3310480 |
1-O,2-O,3-O,4-O,6-O-Pentakis(trimethylsilyl)-D-glucopyranose |
19126-99-9 |
95% |
Y1314726 |
1-BroMo-1,1,2,2,4,5,5,7,8,8,10,11,11,13,14,14,16,16,17,17,17-henicosafluoro-4,7,10,13-tetrakis(trifluoroMethyl)-3,6,9,12,15-pentaoxaheptadecane |
1482416-52-3 |
94% |
Y1344741 |
1-methyl 4-(2-carboxyvinyl)benzoate |
19473-96-2 |
95% |
Y3128756 |
Fluorexon |
154071-48-4 |
95% |
Y3162677 |
2-Chloro-ethanaMine-d4 Hydrochloride |
172333-26-5 |
95% |
Y1257878 |
1,5-Naphthalenebis(trifluoroMethanesulfonate) |
152873-79-5 |
98% |
Y3293524 |
o-FlutaMide |
151262-93-0 |
95% |
Y3311256 |
4,5-Didehydro BriMonidine |
151110-15-5 |
95% |
Y3314249 |
5,5'-DibroMo-3,3'-dihexyl-2,2'-bithiophene |
170702-05-3 |
97% |
Y1262209 |
Dehydro Olmesartan |
172875-98-8 |
99% |
Y3167649 |
6-chloro-8-methylquinoline |
19655-50-6 |
95% |
Y1344173 |
ACOLBIFENE |
151533-34-5 |
99% |
Y1262143 |
1,3-DiMethoxy-2,4-difluorobenzene |
195136-69-7 |
97% |
Y3168000 |
2-Hydroxy Desipramine |
1977-15-7 |
95% |
Y3170472 |
Alatrofloxacin Mesylate |
146961-77-5 |
95% |
Y3294045 |
N-[4-[2-(2-AMino-4,5,6,7-tetrahydro-4,6-dioxo-1H-pyrrolo[2,3-d]pyriMidin-5-yl)ethyl]benzoyl]-L-glutaMic Acid |
193281-00-4 |
95% |
Y3305219 |
WIN 54461 |
166599-63-9 |
99% |
Y1014834 |
3-[4-(Methoxycarbonyl)phenyl]propanoic acid |
151937-09-6 |
95+% |
Y3128741 |
N-[(9S)-8alpha-Cinchonan-9-yl]quinoline-8-sulfonaMide |
1440939-88-7 |
98.0%(HPLC) |
Y1257938 |
3-METHOXY-2,2-DIMETHYLPROPYLAMINE |
171268-71-6 |
95% |
Y3290337 |
Piperazine, 2,5-dimethyl-1-(2-propenyl)-, (2R,5S)- (9CI) |
155836-78-5 |
95% |
Y3128498 |
2,6-Bis[(2S,3S)-4-Methyl-5,5-diphenyloxazolidin-2-yl]pyridine |
1450841-25-4 |
95% |
Y1262160 |
H-PHE-CYCLOHEXYLAMIDE |
17186-53-7 |
99% (TLC) |
Y3156133 |
Pivalolactone. |
1955-45-9 |
95% |
Y3169691 |
1-Piperazineacetamide, N-(2,6-dimethylphenyl)-4-[2-hydroxy-3-(2-hydroxyphenoxy)propyl]- |
172430-45-4 |
95% |
Y1376924 |
2,4-DiMethoxy-3,5-difluorobenzenaMine |
195136-67-5 |
95% |
Y1262120 |
(2R,4S)-Boc-4-phenyl-pyrrolidine-2-carboxylic acid |
144069-70-5 |
97% (HPLC) |
Y1262294 |
3-(1-Methylethyl)-6-(phenylMethyl)-2(1H)-pyrazinone |
170713-71-0 |
97% |
Y3313064 |
4-Octylphenethyl methanesulfonate |
162358-06-7 |
98% |
Y3127100 |
DIATRIZOIC ACID RELATED COMPOUND A (50 MG) (5-ACETAMIDO-3-AMINO-2,4,6-TRIIODOBENZOIC ACID) |
1713-07-1 |
95% |
Y1340080 |
4-Bromo-5H-dibenzo[a,d]cyclohepten-5-one |
17044-50-7 |
98% |
Y3126934 |
PF 2825 |
153012-65-8 |
95% |
Y3159798 |
4-[3-[4-Cyano-3-(trifluoroMethyl)phenyl]-5,5-diMethyl-4-oxo-2-thioxo-1-iMidazolidinyl]-2-fluoro-N-(Methyl-d3)benzaMide |
1443331-82-5 |
99% |
Y3288099 |
11-beta,17-alpha,21-trihydroxy-6-alpha-methylpregn-4-ene-3,20-dione |
1625-39-4 |
99% |
Y1314607 |
1,4-Naphthalenebis(trifluoroMethanesulfonate) |
152873-78-4 |
98% |
Y1262229 |
(3beta,6E)-9,10-secocholesta-5(10),6,8-trien-3-ol |
17592-07-3 |
80% |
Y1339864 |
3-(cyclopentyloxy)-N-(3,5-dichloro-4-pyridyl)-4-methoxybenzamide |
144035-83-6 |
99% |
Y3296367 |
(4-NITRO)PHENYL-2,3,4,6-TETRA-O-ACETYL-ALPHA-D-GALACTOPYRANOSIDE |
17042-39-6 |
95% |
Y1262295 |
[(1S)-2-[[(tert-Butyl)diMethylsilyl]oxy]-1-(hydroxyMethyl)ethyl]-carbaMic Acid tert-Butyl Ester |
185692-85-7 |
95% |
Y3308709 |
Rimeporide Hydrochloride |
187870-95-7 |
99% |
Y3162537 |
BriMonidine-2,3-dione |
182627-95-8 |
95% |
Y3314211 |
D-myo-Inositol, 1-(2R)-2,3-bis(1-oxohexadecyl)oxypropyl hydrogen phosphate 3-(dihydrogen phosphate) |
165689-81-6 |
95% |
Y1253327 |
2-[(4S)-4,5-dihydro-4-phenyl-2-oxazolyl]- Pyridine |
153880-57-0 |
97% |
Y3288341 |
DESACETYLNIMBIN |
18609-16-0 |
95.0% |
Y3309976 |
BisindolylMaleiMide XI Hydrochloride |
145333-02-4 |
98% |
Y3128139 |
Ethanone, 1-(2,6-dimethyl-3-pyridinyl)- (9CI) |
1721-25-1 |
97% |
Y3310524 |
MONO-6-O-MESITYLENESULFONYL-GAMMA-CYCLODEXTRIN |
174010-62-9 |
90%(HPLC) |
Y1262049 |
Pyrrolo[1,2-a]pyrazine-3-acetic acid, 7-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]octahydro-1,4-dioxo-, (3S,7S,8aS)- (9CI) |
184700-26-3 |
97% (HPLC) |
Y1344466 |
2-PIPERIDINOETHYL 4-AMINO-5-CHLORO-2-METHOXYBENZOATE |
186826-17-5 |
99% |
Y1257677 |
trans-Bis(dicyclohexylphenylphosphino)nickel(II) chloride |
19232-03-2 |
95% |
Y3168019 |
3-CHLORO-5-(TRIFLUOROMETHOXY)CINNAMIC ACID |
1588505-18-3 |
95% |
Y1314582 |
TETRASODIUM IMINIDISUCCINATE |
144538-83-0 |
95% |
Y1235672 |
1-(PIPERIDIN-1-YLMETHYL)-1H-BENZIMIDAZOLE |
19213-19-5 |
97% |
Y3147811 |
9-METHYL-6-(TRIFLUOROMETHYL)-9H-PURIN-2-AMINE |
1744-14-5 |
95% |
Y1257701 |
ETHYL 5-AMINO-1-(4-METHOXYPHENYL)-1H-PYRAZOLE-4-CARBOXYLATE |
15001-13-5 |
90% |
Y1262050 |
2-[(4-METHYLPHENYL)THIO]PYRIDINE-3-CARBONYL CHLORIDE |
175135-78-1 |
97% |
Y1261937 |
6-(2,3,3-TRIMETHYLINDOL-1-YL)-HEXANOIC ACID BROMIDE |
171429-43-9 |
95% |
Y3147808 |
3-((4-FLUOROPHENYL)AMINO)CYCLOHEX-2-EN-1-ONE |
191089-78-8 |
95% |
Y3292464 |
CHPG |
170846-74-9 |
98% |
Y3311577 |
7-HYDROXY-5-METHYLFLAVONE |
15235-99-1 |
HPLC =90% |
D760979 |
ALISOL ACETATE B |
19865-76-0 |
97% |
Y1262051 |
(R,S)-Z-3-AMINO-5-CYCLOHEXYL-2-OXO-1,4-BENZODIAZEPINE |
146373-94-6 |
99% (HPLC) |
Y3159799 |
(3-CYANO-4-METHYL-6-OXO-1,6-DIHYDROPYRIDIN-2-YL)THIO]ACETIC ACID |
134616-73-2 |
95% |
Y3160009 |
Cyclohexanone, 3-ethoxy- (8CI,9CI) |
13619-73-3 |
95% |
Y3155959 |
Cyclopentanecarboxylic acid, 3-methyl-, methyl ester, trans- (9CI) |
126110-37-0 |
95% |
Y1344799 |
Cyclopentanol,2-amino-,(1S,2R)-(9CI) |
135969-63-0 |
95% |
Y3156134 |
Cyclopentanecarboxamide, 2-amino-N-methyl-, (1R,2S)-rel- (9CI) |
135053-13-3 |
95% |
Y3309800 |
2-butoxyethyl dihydrogenphosphate |
14260-98-1 |
95% |
Y3312359 |
(E)-1,2-Bis(2-pyridinyl)ethene |
13341-40-7 |
98.0% |
Y3307918 |
deriglidole |
122830-14-2 |
99% |
Y3314259 |
ellagic acid 4-O-xylopyranoside |
139163-18-1 |
98% |
Y3159736 |
Ethanone, 1-(4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-3-yl)- (9CI) |
126571-48-0 |
95% |
Y3168641 |
Ethanone, 1-(2,2-difluoro-1-methylcyclopropyl)- (9CI) |
128073-32-5 |
95% |
Y3160355 |
Ethanone, 1-[1-(1-methylethyl)-1H-1,2,3-triazol-4-yl]- (9CI) |
134926-95-7 |
95% |
Y3153491 |
Ethanone, 1-(2-amino-3-fluorophenyl)- (9CI) |
124623-26-3 |
95% |
Y3160271 |
Ethanone, 1-(1-ethyl-1H-1,2,3-triazol-4-yl)- (9CI) |
134926-94-6 |
95% |
Y3290186 |
Ethanone, 2-bromo-1-(2,2-difluoro-1-methylcyclopropyl)- (9CI) |
128073-31-4 |
95% |
D770686 |
ETHYL ALPHA-CYANO-2-NITRO-4-(TRIFLUOROMETHYL)PHENYLACETATE |
13544-04-2 |
95% |
Y3139060 |
2,6-dibromo-4-methylbenzoic acid |
128733-74-4 |
95% |
Y3309394 |
1ß,4a-Dibromocyclohexane |
13618-83-2 |
95% |
Y3160364 |
Ethyl-piperidin-2-ylmethyl-carbamic acid tert-butyl ester |
1260651-30-6 |
95% |
D770687 |
2,2-DIFLUORO-1-METHYLCYCLOPROPANAMINE HYDROCHLORIDE |
128230-76-2 |
95% |
Y3165566 |
4-ETHYL-PIPERIDINE-1,2-DICARBOXYLIC ACID 1-TERT-BUTYL ESTER |
123811-84-7 |
95% |
Y1257702 |
ETHYL (2E)-3-PYRIMIDIN-5-YLACRYLATE |
123530-61-0 |
95% |
Y3154561 |
2,2'-dihydroxy-3,3'-di-tert-butyl-5,5'-dimethoxydiphenyl |
14078-41-2 |
95% |
Y3315905 |
dihydronitidine |
13063-06-4 |
98% |
Y3311494 |
1-(3,4-dihydroxyphenyl)-2-(3-(4-carbamylphenyl)-1-methylpropylamino)ethanol |
130783-39-0 |
99% |
Y3305503 |
2,3-Dimethyl-6-nitro-1H-indole |
13801-00-8 |
95% |
Y3118394 |
1,3-Dimethoxy-10-methyl-9(10H)-acridinone |
13082-10-5 |
95%+ |
Y3118493 |
Ethyl 6-(hydroxy(oxido)amino)-2-oxo-2H-chromene-3-carboxylate |
13373-28-9 |
95% |
Y1336804 |
3-[[4-(1,1-DIMETHYLETHYL)PHENYL]METHYL]-PIPERIDINE |
136421-92-6 |
97% |
Y1257703 |
dimethyl 1,1'-ferrocenedicarboxylate |
1273-95-6 |
98% |